General Range

Conistat-Gold 10

Novalab Cardiac Diabetic CarePanchkula, Haryana

Conistat-Gold 10 Capsules by Novalab Cardiac & Diabetic Care contain Rosuvastatin, Clopidogrel and Aspirin, a prescription combination of a lipid-lowering medicine and two antiplatelet agents used for cardiovascular risk management in selected patients.

Rosuvastatin belongs to the statin class of medicines. It works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. This action helps reduce LDL cholesterol levels and lowers the risk of certain cardiovascular events associated with atherosclerosis.

Clopidogrel is an antiplatelet medicine that inhibits the platelet P2Y12 receptor, reducing platelet activation and aggregation. Aspirin works by irreversibly inhibiting platelet cyclooxygenase-1 (COX-1), decreasing thromboxane A2 production and further reducing platelet aggregation.

Together, Aspirin and Clopidogrel provide dual antiplatelet therapy, while Rosuvastatin supports cholesterol management and atherosclerotic cardiovascular risk reduction.

Conistat-Gold 10 Capsules may be prescribed for selected patients with coronary artery disease, a history of myocardial infarction, acute coronary syndrome or following coronary angioplasty and stent placement when combined statin and dual antiplatelet treatment is clinically appropriate.

The duration of therapy depends on the patient's cardiovascular condition, coronary intervention history, bleeding risk and individual treatment requirements.

Conistat-Gold 10 Capsules should be taken strictly according to a registered medical practitioner's prescription. Patients should not discontinue antiplatelet treatment without consulting their cardiologist.

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.